+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contrast Enhanced Ultrasound Market - Global Forecast to 2030- Product Image
Contrast Enhanced Ultrasound Market - Global Forecast to 2030- Product Image
Sale

Contrast Enhanced Ultrasound Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014747
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contrast Enhanced Ultrasound Market grew from USD 2.20 billion in 2024 to USD 2.35 billion in 2025. It is expected to continue growing at a CAGR of 6.49%, reaching USD 3.22 billion by 2030.

Contrast Enhanced Ultrasound (CEUS) has emerged as a dynamic imaging technique that elevates diagnostic precision through real-time visualization of vascular flow and tissue perfusion. By leveraging microbubble-based contrast agents in conjunction with advanced ultrasound platforms, clinicians gain access to enhanced lesion characterization, improved detection of microvascular pathology, and noninvasive assessment of organ function. This executive summary outlines the critical developments shaping the CEUS landscape, with a focus on regulatory milestones, technological integrations, and evolving stakeholder expectations. Healthcare providers increasingly favor CEUS for its safety profile, absence of ionizing radiation, and compatibility with bedside imaging, which collectively support cost containment and streamlined workflows. Simultaneously, equipment manufacturers and contrast agent developers continue to push the boundaries of harmonic imaging and microbubble engineering to unlock new clinical applications. As clinical societies refine guidelines and reimbursement frameworks adapt, CEUS stands poised for broader adoption across cardiovascular, neurological, oncology, and obstetric indications. This introduction lays the groundwork for a detailed examination of the underlying shifts, emerging challenges, and opportunities that industry leaders must navigate moving forward.

Transformative Shifts in the Landscape

Over the past several years, the CEUS domain has experienced transformative shifts driven by technological, clinical, and regulatory evolutions. Artificial intelligence algorithms now augment contrast image interpretation, enabling automated lesion detection and quantitative perfusion metrics that reduce interobserver variability. At the same time, point-of-care ultrasound units equipped with contrast harmonic imaging have penetrated emergency and critical care settings, allowing rapid bedside assessments. From a regulatory standpoint, agencies in key geographies have broadened labeled indications for contrast agents to embrace both adult and pediatric populations, fueling off-label exploration into niche applications. Moreover, ongoing R&D efforts have yielded next-generation microbubbles with tailored shell compositions and gas cores that enhance stability and acoustic response. Partnerships between diagnostic centers and technology integrators have become more prevalent, reinforcing the trend toward bundled service offerings. Consequently, these converging forces are redefining stakeholder roles, compelling equipment vendors, contrast suppliers, and healthcare institutions to align their strategies for optimized service delivery and patient outcomes.

Cumulative Impact of United States Tariffs 2025

The imposition of new US tariffs scheduled for 2025 will exert cumulative effects on the cost structure, supply chain resilience, and competitive positioning of CEUS stakeholders. Levies targeting imported ultrasound transducers and raw materials for microbubble production raise the acquisition cost for OEMs, prompting them to reevaluate sourcing strategies. In response, several manufacturers are accelerating partnerships with domestic suppliers and investing in local assembly plants to mitigate duty exposure and lead-time risk. Hospitals and imaging centers, faced with equipment procurement challenges, may defer capital expenditures or negotiate bulk contracts to maintain service continuity. At the same time, contrast agent developers are exploring dual-sourcing agreements and long-term supply commitments to shield against price volatility. These adjustments not only influence pricing dynamics but also foster innovation in material science, as suppliers seek alternative raw materials that fulfill regulatory and acoustic performance requirements. Collectively, these tariff-driven developments are reshaping competitive landscapes and underscoring the importance of agile manufacturing strategies and robust supplier networks.

Key Segmentation Insights

Insight into product type segmentation reveals that intravascular ultrasound adoption continues to expand, with catheter-based and guidewire-based variants increasingly employed for detailed vascular imaging during interventional cardiology procedures. Transabdominal ultrasound solutions-offered in both B-Mode and Color Doppler configurations-remain foundational for abdominal and pelvic assessments, while transcranial Doppler systems leveraging both B-Mode and Color Doppler modes facilitate noninvasive cerebrovascular evaluation. In the domain of transrectal ultrasound, B-Mode and Color Doppler instruments support precise prostate imaging and targeted biopsies. End user segmentation underscores robust uptake in ambulatory surgical settings-comprising freestanding ambulatory and outpatient centers-alongside diagnostic centers that include both clinical diagnostic laboratories and research institutes. Hospitals, spanning private and public facilities, maintain significant imaging volumes, and specialty clinics-particularly cardiology and radiology practices-drive niche CEUS applications. From an application standpoint, cardiovascular imaging remains a leading use case through heart echocardiography and peripheral vascular disease assessment, whereas neurology harnesses brain perfusion imaging and cerebrovascular assessment. Obstetrics and gynecology leverage CEUS for both gynecological condition evaluation and pregnancy monitoring, and oncology employs breast cancer screening alongside liver cancer screening. Technological segmentation is characterized by coded excitation imaging-predominantly binary excitation-contrast harmonic imaging with both high mechanical index and low mechanical index protocols, and traditional harmonic imaging implemented via amplitudoted and pulse inversion techniques. Finally, contrast agent segmentation spans emulsion-based agents, gas-filled microbubbles using nitrogen or perfluorocarbon gas cores, lipid-shelled and protein-shelled microbubbles, and polymer-shelled agents formulated with biodegradable or non-biodegradable polymers. Each segmentation dimension offers distinct performance trade-offs, shaping product roadmaps and clinical adoption strategies.

Key Regional Insights

Regional dynamics in the CEUS market reveal distinct drivers and areas of emphasis across the Americas, Europe/Middle East/Africa, and Asia-Pacific. In the Americas, strong reimbursement frameworks and widespread availability of advanced ultrasound platforms foster high utilization rates in hospitals and ambulatory environments, with demand for contrast-enhanced applications amplified by aging populations and growing chronic disease burdens. Within Europe, Middle East, and Africa, harmonized regulatory processes under the European Medicines Agency and collaborative clinical research initiatives propel cross-border adoption; the region also benefits from public-private partnerships aimed at integrating CEUS into standard diagnostic pathways. Meanwhile, the Asia-Pacific region exhibits rapid expansion supported by government investments in healthcare infrastructure, rising per-capita income in emerging markets, and proactive approval pathways for novel contrast agents. In addition, point-of-care ultrasound devices tailored to rural and community settings address accessibility challenges, while regional manufacturers ramp up localized production to meet domestic demand and navigate import restrictions.

Key Companies Insights

An analysis of key players highlights a competitive landscape defined by diversified portfolios and strategic collaborations. Bracco S.p.A. maintains a leading position in contrast agent development, while Bristol-Myers Squibb Company pursues oncology-focused imaging solutions. Canon Inc. and Canon’s medical imaging division invest heavily in high-resolution transducer technology, and Carestream Health, Inc. integrates CEUS into comprehensive diagnostic imaging suites. Daiichi Sankyo Company, Limited, and Leriva SA explore novel microbubble chemistries for targeted molecular imaging, with support from research institutions such as Mayo Clinic. Canon rival FUJIFILM Corporation and Samsung Medison Co., Ltd. drive innovations in portable, AI-enabled ultrasound platforms. GE HealthCare Technologies Inc., Hitachi, Ltd., Koninklijke Philips N.V., and Siemens AG compete on global distribution networks and software analytics features, while Medtronics PLC and TeraRecon, Inc. focus on image-guided intervention solutions. Lantheus Holdings, Inc., and nanoPET Pharma GmbH pursue regulatory approvals for expanded indications, and emerging companies such as Mobisante, Inc. and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. capitalize on cost-effective offerings tailored to emerging markets. Toshiba Corporation and Trivitron Healthcare Private Limited round out the landscape, emphasizing value chain optimization and clinical partnerships to drive CEUS adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize strategic initiatives that reinforce competitive advantage and address evolving market dynamics. First, diversifying supply chains and investing in regional manufacturing capabilities will buffer against tariff fluctuations and geopolitical disruptions. Second, forging partnerships with academic and clinical research centers accelerates validation of novel contrast agents and imaging protocols, strengthening the evidence base for reimbursement. Third, integrating artificial intelligence and quantitative analytics into ultrasound platforms enhances diagnostic consistency and creates new revenue streams through software subscriptions. Fourth, expanding training programs for sonographers and physicians ensures proficient use of contrast-enhanced techniques, boosting clinical confidence and patient throughput. Fifth, customizing product portfolios to align with key end user segments-such as ambulatory surgical centers and specialty clinics-enables targeted go-to-market strategies. Finally, fostering cross-industry alliances-linking equipment vendors, contrast suppliers, and service providers-drives bundled solutions that capture greater share of diagnostic spending.

Conclusion

In summary, Contrast Enhanced Ultrasound is transforming diagnostic imaging by combining microbubble contrast agents with advanced ultrasound technologies to deliver real-time, high-resolution insights across multiple clinical domains. Technological innovations, shifting regulatory landscapes, and regional policy differences collectively shape the trajectory of CEUS adoption. Although forthcoming tariff measures introduce complexity into supply chain management, they also spur local production and material innovation. A granular understanding of segmentation dimensions-from product type and end user to application, technology, and contrast agent-enables stakeholders to tailor offerings and optimize resource allocation. Regional nuances underscore the importance of adaptive market entry strategies, while competitive analysis reveals ongoing consolidation, collaboration, and organic growth initiatives among leading firms. By executing on targeted recommendations and maintaining a patient-centric focus, industry participants can drive sustainable growth and elevate the standard of care.

Market Segmentation & Coverage

This research report categorizes the Contrast Enhanced Ultrasound Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Intravascular Ultrasound
    • Catheter-Based
    • Guidewire-Based
  • Transabdominal Ultrasound
    • B-Mode
    • Color Doppler
  • Transcranial Doppler
    • B-Mode
    • Color Doppler
  • Transrectal Ultrasound
    • B-Mode
    • Color Doppler
  • Ambulatory Surgical Centers
    • Freestanding Ambulatory Centers
    • Outpatient Centers
  • Diagnostic Centers
    • Clinical Diagnostic Laboratories
    • Research Institutes
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
    • Cardiology Clinics
    • Radiology Clinics
  • Cardiovascular
    • Heart Echocardiography
    • Peripheral Vascular Disease Assessment
  • Neurology
    • Brain Perfusion Imaging
    • Cerebrovascular Assessment
  • Obstetrics And Gynecology
    • Gynecological Conditions
    • Pregnancy Monitoring
  • Oncology
    • Breast Cancer Screening
    • Liver Cancer Screening
  • Coded Excitation Imaging
    • Binary Excitation
  • Contrast Harmonic Imaging
    • High Mechanical Index Imaging
    • Low Mechanical Index Imaging
  • Harmonic Imaging
    • Amplitudoted Harmonic Imaging
    • Pulse Inversion Harmonic Imaging
  • Emulsion-Based Agents
  • Gas-Filled Microbubbles
    • Nitrogen Gas
    • Perfluorocarbon Gas
  • Microbubbles
    • Lipid-Shelled Microbubbles
    • Protein-Shelled Microbubbles
  • Polymer-Shelled Contrast Agents
    • Biodegradable Polymers
    • Non-Biodegradable Polymers

This research report categorizes the Contrast Enhanced Ultrasound Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Contrast Enhanced Ultrasound Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Bracco S.p.A.
  • Bristol-Myers Squibb Company
  • Canon Inc.
  • Carestream Health, Inc.
  • Daiichi Sankyo Company, Limited
  • Esaote S.p.A,
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Lantheus Holdings, Inc.
  • Leriva SA
  • Mayo Clinic
  • Medtronics PLC
  • Mobisante, Inc.
  • nanoPET Pharma GmbH
  • Samsung Medison Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • TeraRecon, Inc.
  • Toshiba Corporation
  • Trivitron Healthcare Private Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Contrast Enhanced Ultrasound Market, by Product Type
8.1. Introduction
8.2. Intravascular Ultrasound
8.2.1. Catheter-Based
8.2.2. Guidewire-Based
8.3. Transabdominal Ultrasound
8.3.1. B-Mode
8.3.2. Color Doppler
8.4. Transcranial Doppler
8.4.1. B-Mode
8.4.2. Color Doppler
8.5. Transrectal Ultrasound
8.5.1. B-Mode
8.5.2. Color Doppler
9. Contrast Enhanced Ultrasound Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Freestanding Ambulatory Centers
9.2.2. Outpatient Centers
9.3. Diagnostic Centers
9.3.1. Clinical Diagnostic Laboratories
9.3.2. Research Institutes
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
9.5. Specialty Clinics
9.5.1. Cardiology Clinics
9.5.2. Radiology Clinics
10. Contrast Enhanced Ultrasound Market, by Application
10.1. Introduction
10.2. Cardiovascular
10.2.1. Heart Echocardiography
10.2.2. Peripheral Vascular Disease Assessment
10.3. Neurology
10.3.1. Brain Perfusion Imaging
10.3.2. Cerebrovascular Assessment
10.4. Obstetrics And Gynecology
10.4.1. Gynecological Conditions
10.4.2. Pregnancy Monitoring
10.5. Oncology
10.5.1. Breast Cancer Screening
10.5.2. Liver Cancer Screening
11. Contrast Enhanced Ultrasound Market, by Technology
11.1. Introduction
11.2. Coded Excitation Imaging
11.2.1. Binary Excitation
11.3. Contrast Harmonic Imaging
11.3.1. High Mechanical Index Imaging
11.3.2. Low Mechanical Index Imaging
11.4. Harmonic Imaging
11.4.1. Amplitudoted Harmonic Imaging
11.4.2. Pulse Inversion Harmonic Imaging
12. Contrast Enhanced Ultrasound Market, by Contrast Agents
12.1. Introduction
12.2. Emulsion-Based Agents
12.3. Gas-Filled Microbubbles
12.3.1. Nitrogen Gas
12.3.2. Perfluorocarbon Gas
12.4. Microbubbles
12.4.1. Lipid-Shelled Microbubbles
12.4.2. Protein-Shelled Microbubbles
12.5. Polymer-Shelled Contrast Agents
12.5.1. Biodegradable Polymers
12.5.2. Non-Biodegradable Polymers
13. Americas Contrast Enhanced Ultrasound Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Contrast Enhanced Ultrasound Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Contrast Enhanced Ultrasound Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Bracco S.p.A.
16.3.2. Bristol-Myers Squibb Company
16.3.3. Canon Inc.
16.3.4. Carestream Health, Inc.
16.3.5. Daiichi Sankyo Company, Limited
16.3.6. Esaote S.p.A,
16.3.7. FUJIFILM Corporation
16.3.8. GE HealthCare Technologies Inc.
16.3.9. Hitachi, Ltd.
16.3.10. Koninklijke Philips N.V.
16.3.11. Lantheus Holdings, Inc.
16.3.12. Leriva SA
16.3.13. Mayo Clinic
16.3.14. Medtronics PLC
16.3.15. Mobisante, Inc.
16.3.16. nanoPET Pharma GmbH
16.3.17. Samsung Medison Co., Ltd.
16.3.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.19. Siemens AG
16.3.20. TeraRecon, Inc.
16.3.21. Toshiba Corporation
16.3.22. Trivitron Healthcare Private Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CONTRAST ENHANCED ULTRASOUND MARKET MULTI-CURRENCY
FIGURE 2. CONTRAST ENHANCED ULTRASOUND MARKET MULTI-LANGUAGE
FIGURE 3. CONTRAST ENHANCED ULTRASOUND MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CONTRAST ENHANCED ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CONTRAST ENHANCED ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTRAST ENHANCED ULTRASOUND MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CATHETER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GUIDEWIRE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY B-MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COLOR DOPPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY B-MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COLOR DOPPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY B-MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COLOR DOPPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY FREESTANDING AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HEART ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY BRAIN PERFUSION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CEREBROVASCULAR ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GYNECOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PREGNANCY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY BREAST CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LIVER CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY BINARY EXCITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMPLITUDOTED HARMONIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PULSE INVERSION HARMONIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMULSION-BASED AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NITROGEN GAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PERFLUOROCARBON GAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LIPID-SHELLED MICROBUBBLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PROTEIN-SHELLED MICROBUBBLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 153. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 155. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 156. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 157. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 158. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 160. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 161. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 165. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 166. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 167. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 168. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 170. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 171. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 172. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 173. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 174. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 175. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 178. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 188. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 189. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 190. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 194. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 195. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 197. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 198. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 270. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 272. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 273. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 274. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 275. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 277. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 278. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 279. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 282. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 283. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 284. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 285. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CODED EXCITATION IMAGING, 2018-2030 (USD MILLION)
TABLE 287. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 288. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, 2018-2030 (USD MILLION)
TABLE 289. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 290. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GAS-FILLED MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 291. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLES, 2018-2030 (USD MILLION)
TABLE 292. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY POLYMER-SHELLED CONTRAST AGENTS, 2018-2030 (USD MILLION)
TABLE 293. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 295. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSABDOMINAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 296. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSCRANIAL DOPPLER, 2018-2030 (USD MILLION)
TABLE 297. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TRANSRECTAL ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 298. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, B

Companies Mentioned

  • Bracco S.p.A.
  • Bristol-Myers Squibb Company
  • Canon Inc.
  • Carestream Health, Inc.
  • Daiichi Sankyo Company, Limited
  • Esaote S.p.A,
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Lantheus Holdings, Inc.
  • Leriva SA
  • Mayo Clinic
  • Medtronics PLC
  • Mobisante, Inc.
  • nanoPET Pharma GmbH
  • Samsung Medison Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • TeraRecon, Inc.
  • Toshiba Corporation
  • Trivitron Healthcare Private Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Contrast Enhanced Ultrasound Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Contrast Enhanced Ultrasound Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 156 Pages
  • Global
From
Contrast Enhanced Ultrasound - Global Strategic Business Report - Product Image

Contrast Enhanced Ultrasound - Global Strategic Business Report

  • Report
  • 359 Pages
  • Global
From
Contrast Enhanced Ultrasound Market Report 2025 - Product Image

Contrast Enhanced Ultrasound Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Contrast-Enhanced Ultrasound Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Contrast-Enhanced Ultrasound Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Specialty Imaging: Fundamentals of CEUS - Product Image

Specialty Imaging: Fundamentals of CEUS

  • Book

About the Contrast Enhanced Ultrasound Market

Contrast Enhanced Ultrasound (CEUS) is a type of ultrasound imaging that uses an intravenous injection of a contrast agent to improve the visibility of blood vessels and other structures within the body. CEUS is used to diagnose and monitor a variety of conditions, including cancer, cardiovascular disease, and liver and kidney diseases. It is also used to assess the effectiveness of treatments such as chemotherapy and radiation therapy. CEUS is a relatively new technology, but it has become increasingly popular in recent years due to its ability to provide detailed images of the body's internal structures. It is also less expensive and less invasive than other imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI). CEUS is used in a variety of medical settings, including hospitals, clinics, and private practices. It is also used in research and clinical trials. Companies that provide CEUS products and services include Siemens Healthineers, Philips Healthcare, GE Healthcare, Toshiba Medical Systems, and Hitachi Medical Systems. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.